A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.

Moffitt Cancer Center, Tampa, Florida, United States

Fort Wayne Medical Oncology and Hematology, Fort Wayne, Indiana, United States

The University of Kansas Cancer Center, Westwood, Kansas, United States

Dana Farber Cancer Institute, Boston, Massachusetts, United States

Washington University School of Medicine, St Louis, Missouri, United States

Fred Hutchinson Cancer Research Center, Seattle, Washington, United States

Blacktown Cancer and Haematology Centre, Blacktown, New South Wales, Australia

Genesiscare St Andrews, Adelaide, South Australia, Australia

Cabrini Hospital Malvern, Malvern, Victoria, Australia

The Alfred Hospital, Melbourne, Victoria, Australia

Rockingham Hospital, Cooloongup, Western Australia, Australia

Linear Clinical Research, Nedlands, Western Australia, Australia

Chu Dijon, Dijon, France

Chu Montpellier Hopital Saint Eloi, Montpellier, France

Iuct Oncopole, Toulouse, France

Queen Elizabeth Hospital, Birmingham, United Kingdom

St Jamess University Hospital, Leeds, United Kingdom